Laminar Pharma Is A Clinical Stage Biopharmaceutical Company Based In Palma De Mallorcaspainfounded In 2006 As A Spin Off From The University Of The Balearic Islandsit Specializes In Membrane Lipid Therapymlt Which Targets Lipid Metabolism In Cell Membranesthe Company Is Dedicated To Translational Health Researchdeveloping Innovative Drugs For Oncologyneurodegenerative Diseasesand Infectious Diseases Laminar Operates Under A B2B Modellicensing Patents And Supplying Molecules To Larger Pharmaceutical Partnersits Mlt Technology Uses Synthetic Lipids To Correct Pathological Lipid Alterationsaiming To Enhance Therapeutic Safety And Efficacythe Company Manages Full Cycle R&Dfrom Laboratory Discovery To Early Clinical Trialsnotable Products In Its Pipeline Include Lam561A Synthetic Lipid Compound For Glioblastoma And Pancreatic Cancerand Programs Targeting Alzheimerae S Disease And Other Infectionslaminar Has Raised $23 03 Million In Funding And Is Preparing For A Public Listing
